Technical Name Influenza mucosal vaccine compositionpreparationapplication thereof
Project Operator National Tsing Hua University
Project Host 吳夙欽
Summary Provided is an influenza mucosal vaccine compositionpreparationapplication thereof. This composition contains an antigen fusion protein which includes an influenza virus antigena Type IIb heat-labile enterotoxin A subunit. Immunization with the antigen fusion protein induces cellularhumoral immune responses, including systemicmucosal immune responses, against a specific in
Technical Film
Scientific Breakthrough Provided is an influenza mucosal vaccine compositionpreparationapplication thereof. This composition contains an antigen fusion protein which includes an influenza virus antigena Type IIb heat-labile enterotoxin A subunit. Immunization with the antigen fusion protein induces cellularhumoral immune responses, including systemicmucosal immune responses, against a specific in
Industrial Applicability The market for seasonal influenza vaccines, sized at US$2.8 billion in 2008–2009 across the major markets, not including the potential of pandemic vaccines. The annual rate of influenza vaccine is approximately 12.6. Our invention provides a mucosal vaccine composition for both humanpoultry vaccine markets. Our invention has already been granted for the patents in USTaiwan.
Keyword Vaccine mucosal intranasal immunization influenza virus hemagglutinin heat-labile enterotoxin A subunit fusion antigen adjuvant
  • Contact
  • 吳夙欽
本網站使用您的Cookie於優化網站。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。